Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash from Financing Activities (2020 - 2025)

Beauty Health (SKIN) has disclosed Cash from Financing Activities for 6 consecutive years, with -$803000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 293.63% to -$803000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$175.2 million, a 7.27% increase, with the full-year FY2024 number at -$158.3 million, down 322.83% from a year prior.
  • Cash from Financing Activities was -$803000.0 for Q3 2025 at Beauty Health, up from -$173.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $637.8 million in Q3 2021 to a low of -$173.4 million in Q2 2025.
  • A 5-year average of $20.2 million and a median of -$1.5 million in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 2497065.23% in 2021, then plummeted 6287.39% in 2024.
  • Beauty Health's Cash from Financing Activities stood at $188.2 million in 2021, then crashed by 154.45% to -$102.5 million in 2022, then surged by 69.4% to -$31.4 million in 2023, then soared by 97.54% to -$770000.0 in 2024, then fell by 4.29% to -$803000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Cash from Financing Activities are -$803000.0 (Q3 2025), -$173.4 million (Q2 2025), and -$250000.0 (Q1 2025).